Home > News > e company
Qianjin Pharmaceutical’s performance report: net profit of 302 million yuan in 2021, a year-on-year increase of 1.62%
2022-01-14 18:07
Source: Securities Times e Company
Author: Xu Qingtianmei
Securities Times · e company
Xu Qingtianmei
2022-01-14 18:07
Securities Times e Company News, Qianjin Pharmaceutical (600479) released a performance report on the evening of January 14. Its operating income in 2021 will be 3.665 billion yuan, a year-on-year increase of 1.06%; the net profit attributable to the parent is 302 million yuan, a year-on-year increase of 1.62%; The stock income was 0.72 yuan.
Disclaimer: Securities Times strives for true and accurate information. The content mentioned in the article is for reference only and does not constitute substantive investment advice. Operational risks are based on this.
.gif)
Securities Times APP
.gif)
WeChat public account
4074747
Qianjin Pharmaceutical’s performance report: net profit of 302 million yuan in 2021, a year-on-year increase of 1.62%
6885
e company
news
1445
Xu Qingtianmei
2022-01-14